INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 42h ago
HOUSE PTR2h ago
SEC 13F2h ago
ROBINHOOD CHAIN2h ago
Public company

TAKTAKEDA PHARMACEUTICAL CO LTD

CIK 0001395064

EDGAR filingsOpen in network
Disclosed transactions2
Buys / sells0 / 2
Max Insider Score39
Connections4with evidence

TAK · disclosed activity on price

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
39
PR
Platford Giles RichardPresident, IBU
TAKTAKEDA PHARMACEUTICAL CO LTD
Open-market sale
SELL$1.16M
55.6K sh
Nov 4, 2026Nov 5, 2026
traded Nov 4, 2026
+1dSEC FORM 4

Evidence

Verified connections

  • ← Insider ofevidence
    Platford Giles RichardPresident, IBU · Nov 5, 2026
  • In industryevidence
    Pharmaceuticals, devices & health servicesSEC SIC 2834 · Pharmaceutical Preparations · Nov 4, 2026
  • ← Insider ofevidence
    Bitetti Teresa MariePresident, OBU · Nov 4, 2026
  • ← Lobbied forevidence
    MR. BRIAN KELLYLDA 1TY 2026 first quarter · issues not listed · Aug 26, 2026
36
BM
Bitetti Teresa MariePresident, OBU
TAKTAKEDA PHARMACEUTICAL CO LTD
Open-market sale
SELL
$974K
46.6K sh
Nov 2, 2026
Nov 4, 2026
traded Nov 2, 2026
+2d
SEC FORM 4

Evidence

Lobbying

$0 reported · de-duplicated
2026 Q1 $0 via firms
  • MR. BRIAN KELLY—2026 Q1 · posted Aug 26, 2026 ·

Connected PAC contributions

FEC · direct to members

No contributions from a PAC connected to this company.